The therapeutical potential of FOSL1 silencing has been proven in orthotopic mouse models, in which the shRNA-mediated Fra-1 knockdown suppressed lung metastasis and restored epithelial features of breast cancer cells [34]. The gene discussed is FOSL1; the disease is breast carcinoma.